mTOR-dependent cell survival mechanisms

Chien-Min Hung1, Luisa Garcia-Haro, Cynthia A Sparks

  • 1Program in Molecular Medicine, University of Massachusetts Medical School, Worcester, MA 01605, USA.

Insights

The mechanistic target of rapamycin (mTOR) kinase regulates cell growth and survival. This review discusses how mTORC1 and mTORC2 complexes respond to nutrient and growth factor signals to control cell fate during stress.

Area of Science:

  • Cell Biology
  • Molecular Biology
  • Biochemistry

Background:

  • The mechanistic target of rapamycin (mTOR) kinase is a critical regulator of cell growth, proliferation, and survival.
  • mTOR exists in two distinct complexes, mTORC1 and mTORC2, with different upstream regulators and downstream targets.
  • Dysregulation of mTOR signaling is implicated in diseases such as cancer, diabetes, and aging.

Purpose of the Study:

  • To review the mechanisms by which mTORC1 and mTORC2 regulate cell survival.
  • To explore how mTOR signaling integrates nutrient availability, growth factor signaling, and cellular stresses.
  • To highlight the role of mTOR as a central signaling hub for cellular metabolism and energy homeostasis.

Main Methods:

  • Literature review of mTOR signaling pathways.
  • Analysis of upstream regulatory signals for mTORC1 and mTORC2.
  • Discussion of downstream substrates and their role in cell survival.

Main Results:

  • mTORC1 senses nutrient availability and growth factor signals, influencing cell growth and survival.
  • mTORC2 primarily responds to growth factors and its role in cell survival is less understood.
  • Both complexes integrate diverse signals to maintain cellular metabolism and energy balance.

Conclusions:

  • mTOR signaling is a key determinant of cell survival in response to various stresses.
  • Understanding mTOR complex function is crucial for developing therapeutic strategies for diseases linked to mTOR dysregulation.
  • Further research is needed to fully elucidate the mechanisms of mTORC2 in cell survival.

Related Concept Videos

mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
Cellular Injury V: Apoptosis and Autophagy01:22

Cellular Injury V: Apoptosis and Autophagy

Cells respond to damage and stress through highly coordinated processes that decide whether they survive or undergo controlled self-destruction. Two major pathways involved in this regulation are apoptosis, a type of programmed cell death, and autophagy, a survival mechanism that helps cells adapt to adverse conditions.ApoptosisApoptosis removes aged or injured cells to maintain tissue balance. During this process, the cell shrinks, chromatin condenses and fragments, and membrane-bound...